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An important aspect of the development of systems biology approaches in metazoans is the characterization of
expression patterns of nearly all genes predicted from genome sequences. Such “localizome” maps should provide
information on where (in what cells or tissues) and when (at what stage of development or under what conditions)
genes are expressed. They should also indicate in what cellular compartments the corresponding proteins are
localized. Caenorhabditis elegans is particularly suited for the development of a localizome map since all its 959 adult
somatic cells can be visualized by microscopy, and its cell lineage has been completely described. Here we address
one of the challenges of C. elegans localizome mapping projects: that of obtaining a genome-wide resource of C. elegans
promoters needed to generate transgenic animals expressing localization markers such as the green fluorescent
protein (GFP). To ensure high flexibility for future uses, we utilized the newly developed MultiSite Gateway system.
We generated and validated “version 1.1” of the Promoterome: a resource of ∼6000 C. elegans promoters. These
promoters can be transferred easily into various Gateway Destination vectors to drive expression of markers such as
GFP, alone (promoterGFP constructs), or in fusion with protein-encoding open reading frames available in ORFeome
resources (promoterORFGFP).
[All clones in promoterome v1.1 are available to the scientific community through Open Biosystems
(http://www.openbiosystems.com) and MRC geneservice (http://www.hgmp.mrc.ac.uk/geneservice).]
Biological processes result from complex networks of interactions
between proteins, nucleic acids, and metabolites (Barabasi and
Oltvai 2004). Although conventional approaches aimed at dis-
covering the function of genes one-at-a-time have been success-
ful at elucidating many biological principles, they are not well
suited to unravel the structure, function, and dynamics of com-
plex molecular networks. With the availability of (nearly) com-
plete genome sequences, approaches have been developed re-
cently to investigate the systems properties of biological net-
works (Ideker et al. 2001; Vidal 2001; Kitano 2002).
The C. elegans genome annotation provided the first draft of
a comprehensive set of metazoan genes (The C. elegans Sequenc-
ing Consortium 1998). Subsequently, genome-wide expression
profiling experiments (transcriptome mapping; Reinke et al.
2000; Kim et al. 2001), high-throughput (HT) RNAi analyses
(phenome mapping; Fraser et al. 2000; Gonczy et al. 2000; Piano
et al. 2000; Kamath et al. 2003; Simmer et al. 2003) and HT yeast
two-hybrid projects (interactome mapping; Walhout et al. 2000a,
2002; Davy et al. 2001; Boulton et al. 2002; Reboul et al 2003; Li
et al. 2004) were used to initiate studies of various biological
processes in the worm at a systems level. However, the ap-
proaches mentioned above mainly probe the structure of the
proteome network and the function of its components, without
providing precise information on dynamic aspects. Thus addi-
tional information is needed about gene expression patterns at
the cellular and/or subcellular levels (“localizome” mapping). Ul-
timately, localizome maps should provide information on where
(in what cells or tissues) and when (at what stage(s) of develop-
ment or under what conditions) genes are expressed. They
should also indicate in what cellular compartments the corre-
sponding proteins are localized.
Gene expression pattern information is being collected for
multiple species, including human (http://bodymap.ims.u-
tokyo.ac.jp/), mouse (http://genex.hgu.mrc.ac.uk/, http://
www.informatics.jax.org/menus/expression_menu.shtml), Xeno-
pus (http://www.dkfz-heidelberg.de/abt0135/axeldb.htm), and
C. elegans (http://129.11.204.86:591/, http://nematode.lab.
nig.ac.jp/db/index.html/). These projects employ different tech-
niques, such as antibody staining, mRNA collection from specific
tissues, reporter genes strategies and in situ mRNA localization to
generate gene expression pattern data.
Each approach has specific advantages and disadvantages,
and provides information on different aspects of gene expres-
sion. For example, antibody staining provides direct information
about protein localization in vivo, but the time and cost involved
in generating antibodies for each predicted protein currently pre-
cludes application of this technique on a proteome-wide scale.
Expression patterns can also be determined by in situ hybridiza-
tion against specific mRNAs, as currently employed for C. elegans
(Tabara et al. 1996). The drawbacks of this technique include
potentially high background levels and potential cross-
hybridization to homologous mRNAs. Finally, expression pat-
terns can be determined by generating transgenic animals carry-
ing promoters fused in vitro to LacZ (Hope 1991) or GFP (Chalfie
et al. 1994) reporter genes.
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The GFP reporter strategy has important advantages for lo-
calizome studies. First, GFP expression can be examined in living
animals, thus changes in GFP expression levels and patterns can
be followed over time during development. Second, GFP can also
be expressed as a fusion with an endogenous ORF to investigate
subcellular localization in vivo. Such GFP-based localizome data
have already proven extremely valuable in yeast (Kumar et al.
2002; Huh et al. 2003). Finally, once a GFP reporter strain has
been created, it can be used repeatedly to examine changes in
expression in response to external stimuli, pharmacological
agents or alterations of gene function. For these reasons, we
chose to utilize the GFP reporter strategy to generate expression
pattern data for C. elegans. This approach requires the production
of C. elegans transgenic strains expressing GFP under the control
of a variety of worm promoters (Hope et al. 1998). Here we de-
scribe the cloning of the initial version of a C. elegans promoter
resource or “promoterome,” and how this resource can be used to
generate gene expression pattern and protein localization data.
Ideally, a promoterome resource should have many other
downstream applications, such as the study of physical interac-
tions between promoters and the transcription complexes that
regulate them. A global map of protein-DNA interactions would
greatly benefit our understanding of the regulatory mechanisms
that give rise to the expression patterns observed in vivo. Ap-
proaches used to investigate protein–DNA interactions include
the yeast one-hybrid system (Deplancke et al. 2004) and chro-
matin immunoprecipitation followed by DNA microarray analy-
sis (ChIP-CHIP or chip2). The latter has been successfully used to
generate a map of the yeast transcriptional regulatory network
(Lee et al. 2002). The availability of a cloned C. elegans promot-
erome will facilitate the production of both yeast one-hybrid
reporter constructs and promoters microarray.
To generate a promoterome re-
source that can be easily transferred to a
variety of vectors we decided to use a
novel implementation of the Gateway
technology (Hartley et al. 2000; Wal-
hout et al. 2000b). In addition to the ver-
satility of the original Gateway recombi-
national cloning system, MultiSite Gate-
way (Cheo et al. 2004) allows the
transfer of two or more DNA fragments
from different Entry clones into a single
Destination vector. Promoters are thus
flanked by attL4 and attR1 sites, so that
promoterome Entry clones can be
cloned in fusion with ORFeome Entry
clones, which are flanked by attL1 and
attL2 recombination sites (Reboul et al.
2003). In summary, thanks to Multisite
Gateway, both resources can be used ei-
ther independently or together (Fig. 1).
RESULTS
Use of MultiSite Gateway
to Generate promoterGFP
and promoterORFGFP
Transgenic Worms
The flexibility of the MultiSite Gateway
recombinational cloning system de-
scribed in this issue (Cheo et al. 2004)
allows HT generation of various types of
gene fusion constructs needed for differ-
ent genome-wide localizome projects.
Since our goals are to generate and analyze both promoterGFP
and promoterORFGFP fusions, we confirmed that promoter se-
quences flanked by the Gateway sites attB4 and attB1 (B4-
promoter-B1-GPF-B2) can faithfully recapitulate known expres-
sion patterns (see also, Hope et al. 2004 ). Furthermore, we dem-
onstrated that promoter fusions containing attB sites can
appropriately drive the expression of proteins fused to GFP (B4-
promoter-B1-ORF-B2-GFP).
We selected three genes with well-described expression pat-
terns: myo-2 is expressed in pharyngeal muscular cells (Okkema
et al. 1993); mec-7 in a subset of sensory neurons (touch cells;
Hamelin et al. 1992); and hlh-8 in the M lineage and in the adult
vulval muscle cells (Eimer et al. 2002). For each gene, we cloned
into a MultiSite Entry vector a 2.5 kb DNA fragment located
directly upstream of the predicted start codon. PCR amplicons of
these “promoter” sequences were obtained using worm genomic
DNA as template with primers flanked by attB sites (attB4 for the
forward primer and attB1R for the reverse primer), and then
cloned into the pDONR P4-P1R vector to generate attL4-promoter-
attR1 Entry clones. The promoters were subsequently transferred
into pDEST-DD03 Destination vector to generate promoterGFP
fusions (see Methods). Transgenic lines were generated with each
construct using micro particle bombardment (Praitis et al. 2001).
The three resulting expression patterns matched previous obser-
vations obtained with clones not containing any Gateway sites
(Fig. 2). We therefore concluded that the presence of attB sites in
the final construction does not interfere noticeably with proper
expression.
In addition, we established our ability to fuse promoter En-
try clones with ORF Entry clones to analyze the subcellular lo-
calization patterns of proteinGFP fusion constructs. We pro-
duced six distinct promoterORFGFP constructs by combining
Figure 1 Downstream application of cloned ORFeome and promoterome clones. MultiSite Gateway
Recombinational cloning technology allows transfer of attL1-ORF-attL2 and attL4-promoter-attR1 Entry
clones either independently, to attR1-ccdB-attR2 and attR4-ccdB-attL1 destination vectors respectively,
or together into a single attR4-ccdB-attR2 destination vector, while preserving the reading frame and
orientation. The availability of a cloned C. elegans “promoterome” and the corresponding “ORFeome”
should facilitate a vast number of in vivo assays in the worm, such as ectopic expression, subcellular
localization, tissue specific RNAi, and tissue specific rescue experiments. Green: attB site; red: attL site;
yellow: attR site.
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the mec-7 or myo-2 promoters with each of three ORFs
(Y71H2B.4, T26A5.9, and B0035.8) from ORFeome v1.1. Out of
18 clones examined by restriction analysis (three for each con-
struct), 15 displayed the correct fragment pattern on an agarose
gel (not shown). One of each construct was sequenced and found
to encode the expected ORF fused in frame to the GFP encoding
sequence, downstream of the expected promoter.
To examine whether MultiSite-generated fusions recapitu-
late subcellular localization of the ORF, the two constructs har-
boring B0035.8, the histone H2B HIS-48 encoding ORF, were
used to generate transgenic worms (Pmyo-2his-48GFP and
Pmec-7his-48GFP). In both cases expression was observed in the
expected cells, with fluorescence signal located in the nuclei of
these cells as expected for a histone-GFP fusion protein (Fig.
2B,D). This experiment demonstrates the potential of combining
the Gateway cloned promoters with ORFeome clones to produce
promoterORFreporter constructs that accurately reflect both
gene expression pattern and subcellular localization of a protein.
Defining the C. elegans Promoterome
Promoters are commonly defined as DNA regions located up-
stream of transcription start sites and containing the necessary
binding elements for proper transcriptional regulation. However,
gene expression can be regulated by additional cis-acting ele-
ments, or enhancers, that can be located distantly upstream and/
or in the introns, and/or downstream of genes (e.g., Conradt and
Horvitz 1999). In the context of a genome-
wide project it would not be possible to
tackle at once all the complexity of gene
regulation. We thus decided, as a first pass,
to focus on the role of the proximal up-
stream regions in gene expression.
We decided to apply the definition
that was used for S. cerevisiae promoters (Lee
et al. 2002). For each gene, the “promoter”
is defined here as the upstream intergenic
region (IGR), specifically the region of DNA
that spans from the ATG of the ORF to
the extremity of the closest 5 ORF (see
Fig. 3A).
During the cloning of the ORFeome,
we observed that cloning efficiency de-
creases as PCR fragment size increases above
2 kb (Reboul et al. 2001). Therefore, we set
an upper size limit of 2 kb for the PCR frag-
ments to ensure high cloning efficiency.
This size restriction implies that regulatory
elements located more than 2 kb upstream
of the ATG will not be included.
We inspected ∼200 articles describ-
ing expression patterns obtained by a
promoterreporter-approach in C. elegans.
The size of the promoter regions employed
varied from a few hundred base pairs to sev-
eral kilobasepairs and was often dictated by
the location of convenient restriction sites
used in cloning (Fig. 3B). We noted that
many of the published expression patterns
derived from small “promoters” (red bars in
Fig. 3B) encompassing only a fraction of the
actual IGR (blue bars in Fig. 3B), suggesting
that the inclusion of the entire IGR is not
always necessary to obtain specific expres-
sion. Moreover, sequence comparison be-
tween C. elegans and C. briggsae shows a dra-
matic decrease in the level of homology 1500 bp upstream of the
predicted ATG for most genes with a long IGR (G. Achaz, pers.
comm.). Thus our strategy should result in the inclusion of most
upstream cis-regulatory elements.
Several predicted intergenic regions are extremely small (the
smallest IGR is only 3 bp), prompting us to set a lower size limit
of 300 bp. Overall, 60% of predicted IGRs are fully included
within these limits (Fig. 3C). For each predicted gene in the C.
elegans genome, we determined the IGR and designed PCR prim-
ers using the OSP primer prediction software (Hillier and Green
1991).
For the sake of simplicity we refer to the individual clones
constituting the promoterome as “promoter Entry clones”, al-
though they also include the 5 untranslated region and they
might not contain all relevant regulatory sites (Fig. 3A). As
ORFeome clones do not contain the original start codon (Reboul
et al. 2001), our promoter Entry clones also add a translation start
codon to allow proper translation of promoterORFreporter con-
structs.
For this project’s design we used WormBase release WS93,
which predicts 21,583 ORFs in the genome. This number in-
cludes internal splice variants, so the actual number of predicted
start codons is 19,540. The number of actual promoters is further
decreased by the presence of operons in the C. elegans genome,
where a unique promoter drives the expression of several ORFs
(Blumenthal et al. 2002; Lercher et al. 2003). The final count of
unique promoters is 18,151. As a first pass we focused on cloning
Figure 2 GFP expression in transgenic worms generated with MultiSite Gateway constructed
transgenes. (A) GFP expression observed with the Pmyo-2GFP construct. (B) GFP expression ob-
served with the Pmyo-2his-48GFP construct. (C) GFP expression observed with the Phlh-8GFP
construct. (D) GFP expression observed with the Pmec-7his-48GFP construct.
C. elegans Promoterome 1.1
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the promoters of the genes whose translation start prediction
has: (1) not been questioned by the C. elegans ORFeome v1.1
(Reboul et al. 2003), and (2) not changed between WormPep
versions WS9 (the reference for the ORFeome v1.1) and WS93. A
total of 8964 genes fit these criteria, and the corresponding col-
lection of cloned IGRs then constitutes the C. elegans promoter-
ome version 1.1.
Generation of the C. elegans Promoterome 1.1
We PCR-amplified each target promoter from C. elegans genom-
ics DNA, adding attB4 and attB1R Gateway recombination sites at
their 5 and 3 end, respectively (Cheo et al. 2004). We then
introduced the resulting PCR products into the donor vector
pDONR P4-P1R (Invitrogen) using Gateway as described (Wal-
hout et al. 2000b; Reboul et al. 2001). We successfully isolated a
clone of the expected size for 6538 promoters (73%). As shown in
Figure 4A, the initial PCR amplification gave a visible product
95% of the time. Five percent (5%) of the cloning failures can
thus be attributed to the lack of genomic PCR amplification due
either to failed primer synthesis or failed amplification under
standard conditions. The remaining 22% of failures results from
the cumulative loss at each step of the process (Gateway recom-
bination, transformation and/or PCR verification, see Fig. 4B
and Methods). Consistent with previous findings during the
ORFeome project, the cloning efficiency inversely correlates with
the size of the initial PCR product (Table
1). In our analysis, there was no size bias
in the genomic PCR success rate or in the
efficiency of transferring fragments from
Entry clones to Destination vectors (not
shown). We therefore concluded that an
enhanced competitive advantage to-
wards cloning primer–dimers was the
cause of our lower success rate for frag-
ments bigger than 1.5 kb (see Methods).
The identity of each cloned pro-
moter was established by sequencing. Of
6018 good-quality traces (Ewing et al.
1998), 5526 corresponded to the ex-
pected DNA fragment (92%). Most of the
erroneous sequences corresponded to
the Donor vector, which carries an ∼2-kb
sized ccdB cassette that resembles a large
promoter clone by electrophoretic
analysis.
We developed a C. elegans promot
erome database (PromoteromeDB; http://
vidal.dfci.harvard.edu/promoteromedb)
to integrate and disseminate the data
collected in the promoterome-cloning
project. The interface to this database
displays IGR size, primer sequences,
cloning and sequencing information, as
well as links to corresponding entries
in WorfDB (http://worfdb.dfci.harvard.
edu; Vaglio et al. 2003) and WormBase
(http://www.wormbase.org; Stein et al.
2001) for each promoter.
DISCUSSION
The first version of the promoterome
generated here contains a third of the
predicted C. elegans “promoters” in a
cloning format that allows their transfer
into various destination vectors in HT
settings.
Through the production of promoterreporter and
promoterORFreporter constructs the promoterome can be used
to generate gene expression pattern and protein localization data
on a genome-wide scale. However, to date, the generation of
transgenic strains carrying low-copy integrated constructs is a
very tedious and time-consuming process that constitutes the
bottleneck of such a project. It will thus take a collaborative effort
from the C. elegans community to generate gradually evolving
versions of the worm localizome.
As mentioned earlier, the scale of the project described
herein led us to disregard regulatory elements contained in in-
trons and the 3 UTR, or located far upstream of the transcription
start. As a result, a fraction of the expression patterns derived
from the promoterome may not accurately reflect the native ex-
pression pattern of the corresponding proteins as could be ob-
served with antibodies. However, despite these limitations, the
construction of a localizome data set should provide insights into
the function of numerous otherwise uncharacterized genes
(Werner 2003). Moreover, the generation of a standardized local-
izome map should allow integration of this map with other func-
tional genomics data sets. For example, integrating the spatio-
temporal component derived from localization studies with the
interactome map (Li et al. 2004) should allow the generation of
tissue-specific interaction maps that would be more relevant to
biological processes. Indeed, for an interaction to occur in vivo
Figure 3 Defining C. elegans promoterome. (A) Illustration of our Intergenic region (IGR) cloning
strategy. Primers have been designed to amplify the entire IGR when smaller than 2 kb (F54H5.3), the
first 2 kb of the IGR when bigger than 2 kb (F54H5.4), or 300 bp when smaller than 300 bp. (B) Analysis
of previously published “promoters.” We randomly selected 200 publications containing a gene ex-
pression pattern determined by translational or transcriptional fusion. When available (164/200) we
retrieved the length of the upstream DNA fragment (“promoter”) that was used to drive the observed
expression. The sizes of the analyzed region range from 300 bp to 13 kb and mostly represent the
distance to the closest convenient restriction site. In many cases a fraction of the IGR was successfully
used. (C) IGR sizes in C. elegans genome. For each predicted ORF of the C. elegans genome (WS93) the
IGR size was calculated as the distance between the ORF’s predicted ATG and the closest extremity of
the next upstream ORF. For each range of sizes the number of IGR in that range, its proportion in the
genome and the cumulated proportion are indicated.
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both partners have to be present in the same cell/tissue and at the
same time during development and, so far, the C. elegans pro-
tein–protein interaction map fails to take into account the com-
plex manner in which gene expression is regulated.
Loss-of-function phenotypes obtained by RNAi are com-
monly utilized to infer the role of a given gene. Although this
approach is very powerful, only 10.3% of the ORFs assayed gave
rise to an observable phenotype in N2 animals; the use of the
RNAi sensitive mutant strain rrf-3(pk1426) only increased this
number to 12.8% (Simmer et al. 2003). The
promoterome could be used to deliver hair-
pin RNAi constructs to specific tissues or
cells (Wesley et al. 2001). This may facilitate
the identification of phenotypes for genes
or tissues that are refractory to traditional
RNAi delivery.
The availability of the promoterome
should also allow for the production of a
wide variety of GFP reporter strains. These
can be used to characterize phenotypes oth-
erwise too subtle to be observed, as recently
demonstrated in a screen for genes involved
in C. elegans fat accumulation (Ashrafi et al.
2003).
Finally, the promoterome will consti-
tute a tool to study transcriptional regula-
tory networks through protein–DNA inter-
actions studies. Its potential to be applied in
a large-scale yeast one-hybrid setting is
demonstrated elsewhere in this issue (De-
plancke et al. 2004). Overlapping the local-
izome map and the data from protein–DNA
interaction maps should allow better under-
standing of the molecular mechanisms that
drive development. The use of a common
resource of promoters to generate both data
sets should greatly facilitate their integra-
tion and specifically the identification of
transcription-factor binding elements
(TFBEs). The information gathered about
TFBEs in the IGRs should allow the identi-
fication of TFBEs located in other regions
such as the introns, 3 untranslated regions
or even within the ORFs themselves.
The promoterome cloning strategy de-
scribed herein can be easily adapted to
other organisms of interest provided that
its annotated genome sequence is avail-
able. We believe that the combined use of
ORFeomes and promoteromes resources will prove very powerful
to unravel the complexity of gene regulatory networks in various
model organisms.
METHODS
Large-Scale Cloning of Promoters
Individual PCR reactions were performed in a 50-µl reaction vol-
ume using 50 ng of wild-type (N2) C. elegans genomic DNA as
template and one unit of High Fidelity Platinum Taq polymerase
(Invitrogen). To facilitate the analysis of the size of PCR products,
primers (Illumina) were organized in 96-well plates by increas-
ing size of the IGR. PCR products were analyzed on 1% agarose
E-Gels (Invitrogen; Fig. 4A). To clone the PCR products into the
MultiSite Entry vector pDONR P4-P1R (Cheo et al. 2004), 2 µl of
non-purified PCR product was transferred to 8 µl of BP reaction
mix containing 100 ng of Entry vector, 0.5 µl of BP clonase and
2 µl of 5X BP reaction buffer. After overnight incubation at 25°C,
2 µl of BP reaction was transformed into 20 µl of E. coli DH5
thermocompetent cells (Inoue et al. 1990), using ABgene
Thermo-Fast 96-well plates. Transformed cells were spotted on LB
agar+kanamycin plates using a Genmate workstation (Tecan). In
pilot experiments, we isolated eight colonies for each of 94 pro-
moters, to evaluate our background level. We observed that
86.6% of promoters under 1500 bp display the expected size in at
least six out of eight colonies. In contrast, bigger promoters could
be split into two categories: 32% showed at least six out of eight
Table 1. HT Cloning Efficiency Is Related to the Size of the
Target Fragment
IGR size Attempted Cloned
Success
rate
0–500 1548 1454 94
500–1000 1901 1644 86
1000–1500 1214 909 75
1500–2000 791 474 60
>2000 3510 2057 59
Total 8964 6538 73
The success rate of the cloning procedure was estimated based on the
detection of the correct size insert in at least one of the two colonies
examined.
Figure 4 Overview of promoterome cloning procedure. (A) Electrophoretic analysis of the ge-
nomic PCR products. The 8929 PCR reactions were analyzed on 1% agarose E-Gels. Ninety-five
percent (95%) of the reactions gave visible PCR products of the expected size (primer pairs were
arranged so that for each row the product size increases from 300 to 2000 bp). (B) Schematic
representation of large-scale cloning of the C. elegans promoterome. All cloning steps are per-
formed in a 96-well format. Clones of the expected size are consolidated using a Tecan Gemini
robot, and stored both as miniprep DNA and bacterial glycerol stock.
C. elegans Promoterome 1.1
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correctly sized clones, while 68% showed less than two out of
eight correct clones. In most cases the clones of the wrong size
corresponded to primer–dimers. We therefore decided to isolate
two colonies per clone, and select one that displayed the ex-
pected insert size by PCR. All clones displaying the correct insert
size were rearrayed and archived as both bacterial glycerol stocks
and plasmid DNA mini-preps (a schematic of the protocol is
shown in Fig. 4B).
Using Multisite Gateway to Express GFP Constructs
In Vivo
To generate promoterGFP and promoterORFGFP clones, we
generated two MultiSite Gateway compatible destination vectors:
pDEST-DD03 and pDEST-MB14. To generate pDEST-DD03, a
HindIII-KpnI fragment containing the attR4-ccdB-attR2 cassette
was moved from pDEST-6 (Invitrogen) into the unc-119 rescue
vector pDP#MM016b (Praitis et al. 2001). To generate pDEST-
MB14, a KpnI-ApaI fragment containing the GFP encoding se-
quence and the unc-54 3 UTR was moved from pPD95.79 (Fire et
al. 1990) into pDP#MM016b. Next, an EcoRV fragment contain-
ing the attR4-ccdB-attR2 cassette was moved from pDEST-6 (In-
vitrogen) into this construct digested with Acc65I and made
blunt by fill-in with Klenow. The unc-119 rescuing fragment
present in these vectors can be used as a marker to select trans-
genic worms. Multi-Site LR reactions were performed in 10-µl
volumes, but otherwise according to manufacturers specifica-
tions (Invitrogen). Transgenic worm-strains were generated using
a ballistic transformation protocol as previously described (Praitis
et al. 2001).
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